| Oct 10, 2025 |
Oct 15, 2025 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$192.6K |
| Sep 10, 2025 |
Sep 11, 2025 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$159.4K |
| Aug 11, 2025 |
Aug 12, 2025 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$159.1K |
| Jul 10, 2025 |
Jul 14, 2025 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$156.4K |
| Jun 10, 2025 |
Jun 12, 2025 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$155.3K |
| May 12, 2025 |
May 14, 2025 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$158.5K |
| Apr 10, 2025 |
Apr 14, 2025 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$154.5K |
| Mar 10, 2025 |
Mar 12, 2025 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$117.9K |
| Feb 10, 2025 |
Feb 12, 2025 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$149.8K |
| Jan 10, 2025 |
Jan 14, 2025 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$111.2K |
| Dec 10, 2024 |
Dec 12, 2024 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$130.8K |
| Nov 11, 2024 |
Nov 13, 2024 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$131.7K |
| Aug 1, 2024 |
Aug 5, 2024 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
15.0
|
-150
|
-100.00%
|
✓
|
$5.8K |
| Jul 1, 2024 |
Jul 3, 2024 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$72.2K |
| Jun 3, 2024 |
Jun 5, 2024 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$66.5K |
| May 9, 2024 |
May 9, 2024 |
CERUS CORP
|
Director |
Buy |
77.5
|
+2,500
|
2.39%
|
✗
|
$4.7K |
| May 1, 2024 |
May 3, 2024 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$50.8K |
| Apr 1, 2024 |
Apr 3, 2024 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$55.7K |
| Mar 1, 2024 |
Mar 5, 2024 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$51.9K |
| Feb 1, 2024 |
Feb 2, 2024 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
13.8
|
-2,200
|
-100.00%
|
✓
|
$48.4K |
| Jan 2, 2024 |
Jan 4, 2024 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
13.8
|
-2,200
|
-100.00%
|
✓
|
$48.6K |
| Dec 1, 2023 |
Dec 5, 2023 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$56K |
| Nov 1, 2023 |
Nov 3, 2023 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$61.5K |
| Oct 2, 2023 |
Oct 4, 2023 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-2,200
|
-100.00%
|
✓
|
$60.1K |
| Sep 1, 2023 |
Sep 6, 2023 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
22.5
|
-3,750
|
-100.00%
|
✗
|
$123.1K |
| Aug 7, 2023 |
Aug 9, 2023 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
22.5
|
-2,850
|
-100.00%
|
✗
|
$85.9K |
| May 26, 2023 |
May 30, 2023 |
CERUS CORP
|
Director |
Buy |
82.5
|
+5,000
|
4.39%
|
✗
|
$9.5K |
| Mar 3, 2023 |
Mar 7, 2023 |
Jazz Pharmaceuticals plc
|
COO |
Sell |
97.5
|
+8,030
|
17.09%
|
✗
|
$774.7K |
| Nov 10, 2022 |
Nov 14, 2022 |
CERUS CORP
|
Director |
Sell |
26.3
|
-12,500
|
-9.90%
|
✗
|
$48.9K |
| Aug 8, 2022 |
Aug 9, 2022 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
20.0
|
-20,000
|
-100.00%
|
✗
|
$566.7K |
| Mar 3, 2022 |
Mar 9, 2022 |
Jazz Pharmaceuticals plc
|
COO |
Sell |
97.5
|
+8,705
|
17.93%
|
✗
|
$739.3K |
| Jan 3, 2022 |
Jan 5, 2022 |
Jazz Pharmaceuticals plc
|
COO |
Sell |
22.5
|
-1,624
|
-3.24%
|
✗
|
$212.8K |
| Sep 2, 2021 |
Sep 3, 2021 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-7,500
|
-100.00%
|
✓
|
$162.7K |
| Aug 4, 2021 |
Aug 5, 2021 |
CERUS CORP
|
Director |
Sell |
25.0
|
-12,877
|
-12.12%
|
✓
|
$80.5K |
| Jun 2, 2021 |
Jun 4, 2021 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-7,500
|
-100.00%
|
✓
|
$161.1K |
| May 18, 2021 |
May 20, 2021 |
CERUS CORP
|
Director |
Sell |
32.5
|
-5,000
|
-7.71%
|
✓
|
$28.7K |
| Apr 5, 2021 |
Apr 7, 2021 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-7,500
|
-100.00%
|
✓
|
$181K |
| Mar 5, 2021 |
Mar 9, 2021 |
Jazz Pharmaceuticals plc
|
COO |
Sell |
20.0
|
-3,718
|
-6.93%
|
✗
|
$612.5K |
| Feb 16, 2021 |
Feb 18, 2021 |
CERUS CORP
|
Director |
Sell |
25.0
|
-10,000
|
-14.31%
|
✓
|
$77.8K |
| Jan 19, 2021 |
Jan 21, 2021 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-5,000
|
-100.00%
|
✓
|
$143.7K |
| Jan 4, 2021 |
Jan 6, 2021 |
Jazz Pharmaceuticals plc
|
COO |
Sell |
20.0
|
-1,607
|
-3.69%
|
✗
|
$257.8K |
| Nov 17, 2020 |
Nov 19, 2020 |
CERUS CORP
|
Director |
Sell |
25.0
|
-10,000
|
-14.31%
|
✓
|
$62.5K |
| Oct 19, 2020 |
Oct 21, 2020 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-5,000
|
-100.00%
|
✓
|
$88.3K |
| Jul 17, 2020 |
Jul 20, 2020 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-5,000
|
-100.00%
|
✓
|
$82.4K |
| May 22, 2020 |
May 27, 2020 |
CORCEPT THERAPEUTICS INC
|
Director |
Sell |
10.0
|
-5,000
|
-100.00%
|
✓
|
$80.5K |
| Mar 5, 2020 |
Mar 9, 2020 |
Jazz Pharmaceuticals plc
|
COO |
Sell |
22.5
|
-1,735
|
-3.84%
|
✗
|
$216K |
| Jan 29, 2020 |
Feb 6, 2020 |
CERUS CORP
|
Director |
Buy |
77.5
|
+1,000
|
2.23%
|
✗
|
$4.2K |
| Jan 3, 2020 |
Jan 6, 2020 |
Jazz Pharmaceuticals plc
|
COO |
Sell |
22.5
|
-1,599
|
-5.20%
|
✗
|
$233.6K |
| Jan 3, 2019 |
Jan 7, 2019 |
Jazz Pharmaceuticals plc
|
COO |
Sell |
22.5
|
-1,604
|
-8.85%
|
✗
|
$202.1K |
| Feb 29, 2016 |
Mar 2, 2016 |
Viracta Therapeutics, Inc.
|
CEO |
Sell |
91.3
|
+81,858
|
21.30%
|
✗
|
$41.8K |
| Aug 24, 2015 |
Aug 26, 2015 |
Viracta Therapeutics, Inc.
|
CEO |
Buy |
86.3
|
+25,000
|
7.06%
|
✗
|
$25.3K |
| Jul 24, 2015 |
Jul 28, 2015 |
Viracta Therapeutics, Inc.
|
CEO |
Sell |
78.8
|
+12,285
|
1.94%
|
✗
|
$18.5K |
| Feb 27, 2015 |
Mar 2, 2015 |
Viracta Therapeutics, Inc.
|
CEO |
Sell |
86.3
|
+18,056
|
6.29%
|
✗
|
$27.2K |
| Aug 27, 2014 |
Aug 29, 2014 |
Viracta Therapeutics, Inc.
|
CEO |
Sell |
48.8
|
-5,000
|
-1.73%
|
✓
|
$40K |
| Feb 28, 2014 |
Mar 4, 2014 |
Viracta Therapeutics, Inc.
|
CEO |
Sell |
78.8
|
+6,224
|
2.48%
|
✗
|
$24.5K |
| Feb 28, 2013 |
Mar 1, 2013 |
Viracta Therapeutics, Inc.
|
CEO |
Sell |
86.3
|
+13,162
|
6.32%
|
✗
|
$39.8K |
| Feb 29, 2012 |
Mar 2, 2012 |
Viracta Therapeutics, Inc.
|
CEO |
Buy |
91.3
|
+75,369
|
34.09%
|
✗
|
$35.2K |
| Nov 28, 2011 |
Nov 30, 2011 |
Viracta Therapeutics, Inc.
|
CEO |
Buy |
77.5
|
+2,500
|
1.52%
|
✗
|
$2.8K |
| Nov 21, 2011 |
Nov 22, 2011 |
Viracta Therapeutics, Inc.
|
CEO |
Buy |
77.5
|
+2,100
|
1.34%
|
✗
|
$2.5K |
| Jul 15, 2011 |
Jul 18, 2011 |
Viracta Therapeutics, Inc.
|
CEO |
Buy |
82.5
|
+5,000
|
3.31%
|
✗
|
$9.9K |
| Feb 28, 2011 |
Mar 2, 2011 |
Viracta Therapeutics, Inc.
|
CEO |
Sell |
91.3
|
+22,897
|
17.84%
|
✗
|
$27.9K |
| Jul 30, 2010 |
Aug 3, 2010 |
Viracta Therapeutics, Inc.
|
CEO |
Sell |
86.3
|
+52,876
|
7.37%
|
✗
|
$14.9K |
| Jun 30, 2010 |
Jul 1, 2010 |
Viracta Therapeutics, Inc.
|
CEO |
Buy |
95.0
|
+476,487
|
1166.35%
|
✗
|
$131K |